Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

ER Smith, ML Ford, LA Tomlinson, BF Rocks… - Clinica Chimica …, 2010 - Elsevier
BACKGROUND: Fetuin-A is a circulating inhibitor of ectopic calcification. Low plasma levels
have been associated in some studies with increased vascular calcification, aortic stiffness …
被引用次数：38 相关文章

Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

ER Smith, ML Ford, LA Tomlinson… - … journal of clinical …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Fetuin-A is a circulating inhibitor of ectopic calcification. Low plasma levels
have been associated in some studies with increased vascular calcification, aortic stiffness …

WITHDRAWN: Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

ER Smith, ML Ford, LA Tomlinson, BF Rocks… - Clinica Chimica …, 2010 - Elsevier
The Publisher regrets that this article is an accidental duplication of an article that has
already been published, doi: 10.1016/j. cca. 2010.04. 020. The duplicate article has …

Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

ER Smith, ML Ford, LA Tomlinson, BF Rocks… - Clinica Chimica …, 2010 - infona.pl
Fetuin-A is a circulating inhibitor of ectopic calcification. Low plasma levels have been
associated in some studies with increased vascular calcification, aortic stiffness and …

Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

ER Smith, ML Ford, LA Tomlinson… - Clinica Chimica Acta; …, 2010 - europepmc.org
Background Fetuin-A is a circulating inhibitor of ectopic calcification. Low plasma levels
have been associated in some studies with increased vascular calcification, aortic stiffness …

[引用][C] Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

ER SMITH, ML FORD, LA TOMLINSON, BF ROCKS… - Clinica chimica acta, 2010 - Elsevier